SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000078003-22-000094
Filing Date
2022-08-10
Accepted
2022-08-10 16:26:18
Documents
93
Period of Report
2022-07-03

Document Format Files

Seq Description Document Type Size
1 10-Q pfe-20220703.htm   iXBRL 10-Q 3852879
2 EX-31.1 pfe-exh311x0703202210q.htm EX-31.1 9179
3 EX-31.2 pfe-exh312x0703202210q.htm EX-31.2 9171
4 EX-32.1 pfe-exh321x0703202210q.htm EX-32.1 4613
5 EX-32.2 pfe-exh322x0703202210q.htm EX-32.2 4594
  Complete submission text file 0000078003-22-000094.txt   16597185

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20220703.xsd EX-101.SCH 87693
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pfe-20220703_cal.xml EX-101.CAL 157942
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20220703_def.xml EX-101.DEF 451680
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20220703_lab.xml EX-101.LAB 950588
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20220703_pre.xml EX-101.PRE 637194
87 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20220703_htm.xml XML 4297427
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-03619 | Film No.: 221152158
SIC: 2834 Pharmaceutical Preparations